Cargando…
Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database
PURPOSE: Eculizumab, a drug that blocks activation of the terminal complement pathway, is useful in the treatment of several rare diseases. However, eculizumab-related meningococcal disease is a serious problem. Because of the difficulty diagnosing meningococcal disease, deaths from meningococcal di...
Autor principal: | Matsumura, Yumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666998/ https://www.ncbi.nlm.nih.gov/pubmed/33204170 http://dx.doi.org/10.2147/DHPS.S257009 |
Ejemplares similares
-
Concerns about unapproved meningococcal vaccination for eculizumab therapy in Japan
por: Tanimoto, Tetsuya, et al.
Publicado: (2014) -
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database
por: Naganuma, Misa, et al.
Publicado: (2018) -
Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
por: Hatahira, Haruna, et al.
Publicado: (2018) -
Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
por: Mizuno, Takahito, et al.
Publicado: (2021) -
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2017)